01-11-2001 | Revisiones
TRAIL/Apo-2L death signaling pathway and molecular targeting agents: implications for chemoresistance
Published in: Clinical and Translational Oncology | Issue 6/2001
Login to get access01-11-2001 | Revisiones
Published in: Clinical and Translational Oncology | Issue 6/2001
Login to get access